Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients.

Schwaab, T; Schwarzer, A; Wolf, B; Crocenzi, TS; Seigne, JD; Crosby, NA; Cole, BF; Fisher, JL; Uhlenhake, JC; Mellinger, D; Foster, C; Szczepiorkowski, ZM; Webber, SM; Schned, AR; Harris, RD; Barth, RJ; Heaney, JA; Noelle, RJ; Ernstoff, MS

doi:10.1158/1078-0432.ccr-08-3240

Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients.

Détails

Demande d'une copie

ID Serval

serval:BIB_6D9AE5F9A769

Type

Article: article d'un périodique ou d'un magazine.

Collection

Publications

Institution

Production externe

Titre

Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients.

Périodique

Clinical Cancer Research

Auteur⸱e⸱s

Schwaab T, Schwarzer A, Wolf B, Crocenzi TS, Seigne JD, Crosby NA, Cole BF, Fisher JL, Uhlenhake JC, Mellinger D, Foster C, Szczepiorkowski ZM, Webber SM, Schned AR, Harris RD, Barth RJ, Heaney JA, Noelle RJ, Ernstoff MS

Statut éditorial

Publié

Date de publication

08/2009

Langue

anglais

DOI

10.1158/1078-0432.ccr-08-3240

Pubmed

19622576

Site de l'éditeur

http://europepmc.org/abstract/med/19622576

Création de la notice

13/09/2022 8:50

Dernière modification de la notice

14/09/2022 6:37

Données d'usage

SERVAL

serveur académique lausannois

Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients.

Détails